Csrp1-KO Mouse
Common Name
Csrp1-KO
제품 ID
S-KO-01672
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-13007-Csrp1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Csrp1-KO Mouse (카탈로그 번호 S-KO-01672)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Csrp1-KO
품종 계통계통 ID
KOCMP-13007-Csrp1-B6J-VA
유전자명
제품 ID
S-KO-01672
유전자 별칭
CRP1, Csrp
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 1
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000097561
NCBI 전사체 ID
NM_001360782
타겟 영역
Exon 3~4
유효 영역 크기
~2.7 kb
유전자 연구 개요
Csrp1, or Cysteine and Glycine-rich Protein 1, belongs to the cysteine-rich protein family and contains a unique double-zinc finger motif. It is important for development and cellular differentiation, and is a marker of smooth muscle lineages [1,2]. Csrp1 has been implicated in various biological processes such as cell morphology regulation via interactions with Dishevelled 2 (Dvl2) and Diversin (Div) in the noncanonical Wnt and JNK pathways [4].
In diseases, abnormal Csrp1 expression is associated with poor prognosis in colon cancer, where higher expression is related to a mesenchymal, stroma-rich tumor profile, epithelial-to-mesenchymal transition (EMT), and a specific consensus molecular subtype (CMS4) [1]. In colon adenocarcinoma, it promotes tumor growth and migration, and higher expression indicates a worse prognosis [2]. In acute myeloid leukemia, it is an independent prognostic factor, correlates with immune-related pathways, and shows differential sensitivity to drugs [3,6]. In prostate cancer, low Csrp1 expression promotes the progression from hormone-sensitive to castration-resistant prostate cancer [5]. In neuroblastoma, it is involved in differentiation, apoptosis, and innate immunity, and can enhance the effects of combination therapies [7]. In cattle, variants of Csrp1 are associated with growth and carcass traits [8].
In conclusion, Csrp1 is crucial for development and cellular differentiation, with its abnormal expression linked to various cancers and hematological diseases. Studies on Csrp1 in different genetic models, though not specifically KO/CKO mouse models in the provided references, have enhanced our understanding of its role in disease progression, potentially guiding future therapeutic strategies.
References:
1. Demirkol Canli, Seçil. 2023. CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer. In Turkish journal of medical sciences, 53, 1678-1689. doi:10.55730/1300-0144.5736. https://pubmed.ncbi.nlm.nih.gov/38813484/
2. Yu, Senlong, Zhao, Haifeng, Meng, Hongjie, Bian, Tianhua, Ruan, Canping. 2023. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. In Genetics research, 2023, 8586507. doi:10.1155/2023/8586507. https://pubmed.ncbi.nlm.nih.gov/37113556/
3. Zhao, Chunxia, Wang, Yulu, Wang, Huan, Schmidt-Wolf, Ingo G H, Wang, Zifeng. 2024. CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response. In Discover oncology, 15, 248. doi:10.1007/s12672-024-01088-9. https://pubmed.ncbi.nlm.nih.gov/38937285/
4. Miyasaka, Kota Y, Kida, Yasuyuki S, Sato, Takayuki, Minami, Mari, Ogura, Toshihiko. 2007. Csrp1 regulates dynamic cell movements of the mesendoderm and cardiac mesoderm through interactions with Dishevelled and Diversin. In Proceedings of the National Academy of Sciences of the United States of America, 104, 11274-9. doi:. https://pubmed.ncbi.nlm.nih.gov/17592114/
5. Pan, Chenxi, Wang, Wei, He, Yi, Yang, Bo. 2025. Identification of CSRP1 as novel biomarker for hormone-sensitive prostate cancer by the combination of clinical and functional research. In Cancer cell international, 25, 65. doi:10.1186/s12935-025-03708-y. https://pubmed.ncbi.nlm.nih.gov/39994616/
6. Hao, Qianqian, Liu, Yu, Liu, Yajun, Wang, Shujuan, Sun, Ling. 2024. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia. In Clinical and experimental medicine, 24, 57. doi:10.1007/s10238-023-01269-w. https://pubmed.ncbi.nlm.nih.gov/38546813/
7. Lin, Yu-Han, Jiang, Jyun-Hong, Chuang, Hui-Ching, Lian, Wei-Shiung, Chuang, Jiin-Haur. . The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor-Suppressive Therapeutic Responses. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 39, e70521. doi:10.1096/fj.202500403R. https://pubmed.ncbi.nlm.nih.gov/40198006/
8. He, Hua, Liu, Xiao-lin, Zhang, Hui-lin, Liu, Yu, Chen, Ling. 2013. SNV and haplotype analysis reveals new CSRP1 variants associated with growth and carcass traits. In Gene, 522, 206-13. doi:10.1016/j.gene.2013.03.030. https://pubmed.ncbi.nlm.nih.gov/23537997/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
